Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

N-acetylcysteine may help treat trichotillomania.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

A woman developed male characteristics after using unregulated hormone therapy.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone treatment may affect heart response to stress in transgender men.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.